SUPERNUS PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

SUPERNUS PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $0.68 (loss) per share for the year ending 2025.

  • SUPERNUS PHARMACEUTICALS, INC. showed a decrease of -151.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from SUPERNUS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), SUPERNUS PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 75.0%.
  • Historical annual values: Fiscal year 2025: $0.68 (loss) per share | Fiscal year 2024: $1.32 per share | Fiscal year 2023: $0.02 per share | Fiscal year 2022: $1.04 per share | Fiscal year 2021: $0.98 per share | Fiscal year 2020: $2.36 per share | Fiscal year 2019: $2.10 per share | Fiscal year 2018: $2.05 per share | Fiscal year 2017: $1.08 per share | Fiscal year 2016: $1.76 per share | Fiscal year 2015: $0.28 per share | Fiscal year 2014: $0.26 (loss) per share | Fiscal year 2013: $2.90 (loss) per share | Fiscal year 2012: $2.72 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: